Vaginal Dysfunction and Bladder Incontinence
Breast Cancer is the most common malignancy affecting women within the United States and can bring about multiple physical and psychological challenges. Among the greatest challenges are those associated with vaginal and bladder function. Chemotherapy, endocrine therapy, surgeries and radiation all have significant effects in altering a women’s bladder control and vaginal function. Bladder incontinence and vaginal atrophy effects a women’s self-image. Concerns about the ability to be intimate occur.
These concerns result in significant emotional stress including depression, sadness and self-doubt related to personal appearance and negative impacts on personal intimate relationships. In this white paper discussion, I will present and review the cutting edge technology of MonaLisa Touch therapy and discuss this technology as part of an effective management and treatment plan for bladder incontinence and vaginal atrophy.
In the United States, breast cancer is the most common cancer in women regardless of race. More and more women are surviving their diagnosis as a result of the combined result of early detection and better therapies. As a result, over 3 million women have a history of breast cancer making them the largest proportion of cancer survivors in the United States. Breast cancer survivors make up over 40% of the entire population of cancer survivors. Cancer survival is complicated with many multiple issues for woman to face. Perhaps the most important issue faced by these women are those related to vaginal and bladder dysfunction which can occur during treatment and extend into long term survivalship.
In many patients while physical and emotional functioning will normalize with time, bladder and vaginal function remains compromised with a reduction in sexual activity with her partner compared to pre-cancer treatment experiences.
Primary symptoms experienced by breast cancer survivors include:
MonaLisa Touch Technology
MonaLisa Touch technology is clinically an effective treatment modality for most women facing vaginal and bladder dysfunction as a result of breast cancer therapy. MonaLisa therapy provides effective treatment for vaginal dysfunction and bladder incontinence related to breast cancer therapy. MonaLisa therapy provides an effective treatment modality to address sexuality and intimacy issues after treatment of breast cancer including both the physical and emotional effects experienced by survivors and removes the barriers of effective treatment with a demonstrated solution to improve overall the quality of life in survivorship. Regardless of sexual orientation and current partner status, MonaLisa Touch technology offers a clinically proven viable treatment option to stabilize and improve vaginal function and to improve bladder incontinence.
Female sexual function encompasses more than just arousal and orgasm. Female sexual function includes desire, arousal, lubrication, orgasm, satisfaction, vaginal comfort, body image, psychological health and sexuality.
MonaLisa Touch technology provides an effective medical treatment for vaginal dysfunction and bladder incontinence. As a result of improved vaginal conditioning and bladder incontinence many woman develop the confidence to resume over time intimate relationships.
Urinary Symptoms in Breast Cancer
Over 50% of women treated for breast cancer have difficulty with bladder control. Treatments commonly associated with menopausal symptoms for breast cancer included chemotherapy and endocrine therapy both of which can have significant effects on bladder function. MonaLisa Touch therapy technology is an effective treatment of breast cancer survival patients with persistent urinary symptoms.
Vaginal Changes in Breast Cancer
One area of life that breast cancer and treatment might change is the ability to have or enjoy sex. Symptoms may include vaginal dryness and tightness; pain when your genital area is touched or pain from sexual intercourse.
Approximately half of survivors of breast cancer and other cancers that effect the pelvic area such as cervical, ovarian, uterine, bladder, or vaginal develop long term sexual problems.
There are many different causes of sexual functioning concerns in female cancer survival. Some are physical others may be due to changes in how you feel about yourself, your body and other aspects of your life after cancer. Most problems experienced by survivors of breast cancer treatment are actually caused by the treatment itself and not the cancer. Examples include:
MonaLisa Touch technology is an effective treatment of breast cancer survivor patients with persistent vagina symptoms.
Sollay Laser Center
Our goal is to educate breast cancer survival patients of the availability of new medical technology capable of improving and in many cases eliminating vaginal dysfunction and bladder associated symptoms including incontinence. The MonaLisa Touch technology is truly an incredible breakthrough in the treatment of breast cancer survival patients who often are significantly disabled both physically and emotionally by bladder dysfunction and vaginal dysfunction.
For the first time MonaLisa Touch technology offers breast cancer survival patients the opportunity to improve their emotional, physical and psychological disability resulting in lifestyle improvements.
Call today for a free consultation where we will discuss your unique symptoms and design a MonaLisa Touch treatment plan especially for you.